» Articles » PMID: 37600424

Brief Review on Ebola Virus Disease and One Health Approach

Overview
Journal Heliyon
Specialty Social Sciences
Date 2023 Aug 21
PMID 37600424
Authors
Affiliations
Soon will be listed here.
Abstract

Ebola virus disease (EVD) is a severe and highly fatal zoonotic disease caused by viruses in the family and genus . The disease first appeared in Zaire near the Ebola River in 1976, now in the Democratic Republic of the Congo. Since then, several outbreaks have been reported in different parts of the world, mainly in Africa, leading to the identification of six distinct viral strains that cause disease in humans and other primates. Bats are assumed to be the main reservoir hosts of the virus, and the initial incidence of human epidemics invariably follows exposure to infected forest animals through contact or consumption of bush meat and body fluids of forest animals harboring the disease. Human-to-human transmission occurs when contaminated body fluids, utensils, and equipment come in contact with broken or abraded skin and mucous membranes. EVD is characterized by sudden onset of 'flu-like' symptoms (fever, myalgia, chills), vomiting and diarrhea, then disease rapidly evolves into a severe state with a rapid clinical decline which may lead potential hemorrhagic complications and multiple organ failure. Effective EVD prevention, detection, and response necessitate strong coordination across the animal, human, and environmental health sectors, as well as well-defined roles and responsibilities evidencing the significance of one health approach; the natural history, epidemiology, pathogenesis, and diagnostic procedures of the Ebola virus, as well as prevention and control efforts in light of one health approach, are discussed in this article.

Citing Articles

Viruses Identified in Shrews () and Their Biomedical Significance.

Gong H, Chen R, Tan S, Wang X, Chen J, Zhang Y Viruses. 2024; 16(9).

PMID: 39339918 PMC: 11437491. DOI: 10.3390/v16091441.


National burden of Ebola virus disease in Democratic Republic of the Congo: the urgency to act.

Ahmad B, Sagide M, Ntamwinja S, Byiringiro E, Kihanduka E, Rugendabanga E Ann Med Surg (Lond). 2024; 86(8):4579-4585.

PMID: 39118744 PMC: 11305799. DOI: 10.1097/MS9.0000000000002213.


Recent Advances in Therapeutic Approaches Against Ebola Virus Infection.

Soni M, Tulsian K, Barot P, Vyas V Recent Adv Antiinfect Drug Discov. 2024; 19(4):276-299.

PMID: 38279760 DOI: 10.2174/0127724344267452231206061944.


Modeling Supply and Demand Dynamics of Vaccines against Epidemic-Prone Pathogens: Case Study of Ebola Virus Disease.

Guttieres D, Diepvens C, Decouttere C, Vandaele N Vaccines (Basel). 2024; 12(1).

PMID: 38250837 PMC: 10819028. DOI: 10.3390/vaccines12010024.

References
1.
Eisfeld A, Halfmann P, Wendler J, Kyle J, Burnum-Johnson K, Peralta Z . Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis. Cell Host Microbe. 2017; 22(6):817-829.e8. PMC: 5730472. DOI: 10.1016/j.chom.2017.10.011. View

2.
Weyer J, Grobbelaar A, Blumberg L . Ebola virus disease: history, epidemiology and outbreaks. Curr Infect Dis Rep. 2015; 17(5):480. DOI: 10.1007/s11908-015-0480-y. View

3.
Jain S, Khaiboullina S, Martynova E, Morzunov S, Baranwal M . Epidemiology of Ebolaviruses from an Etiological Perspective. Pathogens. 2023; 12(2). PMC: 9963726. DOI: 10.3390/pathogens12020248. View

4.
Ladner J, Wiley M, Mate S, Dudas G, Prieto K, Lovett S . Evolution and Spread of Ebola Virus in Liberia, 2014-2015. Cell Host Microbe. 2015; 18(6):659-69. PMC: 4711363. DOI: 10.1016/j.chom.2015.11.008. View

5.
Jacob S, Crozier I, Fischer 2nd W, Hewlett A, Kraft C, de La Vega M . Ebola virus disease. Nat Rev Dis Primers. 2020; 6(1):13. PMC: 7223853. DOI: 10.1038/s41572-020-0147-3. View